How is the Galectin Therapeutics Inc today?

The Galectin Therapeutics Inc today is trading in the down by 0.00% at 1.29.

What is Galectin Therapeutics Inc Annual Net Profit?

Galectin Therapeutics Inc Annual Net Profit fell 14.56% in the last year to $47.05 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Galectin Therapeutics Inc Price to Earning Ratio?

Galectin Therapeutics Inc Price to Earning Ratio is -1.81, which is negative.

What is Galectin Therapeutics Inc Stock Price?

Galectin Therapeutics Inc Stock Price fell 52.04% and underperformed its sector by 83.43% in the past year.

What is Galectin Therapeutics Inc Quarterly Net profit?

Galectin Therapeutics Inc Quarterly Net profit rose 16.17% YoY to $9.63 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Galectin Therapeutics Inc Mutual Fund Holding?

Galectin Therapeutics Inc Mutual Fund Holding decreased by 0.41% in the last quarter to 10.52.

What is Galectin Therapeutics Inc Promoter Share Holding?

Galectin Therapeutics Inc Promoter Share Holding decreased by 0.11% in the most recent quarter to 20.17%.

What is Galectin Therapeutics Inc Interest Coverage Ratio?

Galectin Therapeutics Inc Interest Coverage Ratio is -7.49, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Galectin Therapeutics Inc Institutional Holding?

Galectin Therapeutics Inc Institutional Holding decreased by 0.36% in the last quarter to 15.6.

Galectin Therapeutics Inc XNAS: GALT

Galectin Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Galectin Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Galectin Therapeutics Inc
Rating: 0.81075
Author: Trendlyne DVM scores

about

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...

1.29 0.00 (0.00%)

59.31% Fall from 52W High

49,539 XNAS Volume

XNAS 04 Jun, 2025 1:12 PM (EDT)

Not Eligible

-

Expensive Valuation

0.0 / 100

Technically Bearish

32.4 / 100

No estimates available

Galectin Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Galectin Therapeutics Inc FAQ

How is Galectin Therapeutics Inc today?

Galectin Therapeutics Inc today is trading in the red, and is down by 0.00% at 1.29.

How has Galectin Therapeutics Inc performed historically?

Galectin Therapeutics Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell -1.53%. stock has been down -13.42% in the past quarter and fell -52.04% in the past year. You can view this in the overview section.